DRGS - Global Big Pharma ETN

Description: The index is designed to track the performance of the equity securities of a cross-section of global companies involved in various phases of the development, production and marketing of pharmaceuticals.

Last Updated:

DRGS - Profile


Summary Data for DRGS

52 Week Lo: $37.30 52 Week Hi: $53.35
AUM: $8.5 M Shares: 0.2 M
Avg. Volume (1 month) 814 Avg. Volume (3 month) 887

DRGS - Holdings

Holdings data for DRGS is not available. View the DRGS. Factsheet
© 2014 Morningstar Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

DRGS - Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Download the PDF
It appears you don't have Adobe Reader or PDF support in this web browser. Click here to download the PDF

Having trouble viewing?
Visit Adobe.com to install Adobe Acrobat Viewer.

DRGS - Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of DRGS relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

DRGS - Fundamentals

DRGS Performance

1 Week Return: 0.06%
2 Week Return: 1.39%
4 Week Return: 5.83%
13 Week Return: 7.96%
26 Week Return: 12.37%
YTD Return: 25.04%
1 Year Return: 31.68%
3 Year Return: 124.74%
5 Year Return: n/a

DRGS Expenses & Fees

DRGS Valuation

P/E Ratio: n/a
Beta: 1.76
20 Day Moving Average: $52.10
60 Day Moving Average: $50.62

DRGS Dividend

Annual Dividend Rate: n/a
Dividend Date: n/a
Dividend: n/a
Annual Dividend Yield %: n/a

DRGS Volatility

5 Day Volatility: 102.00%
20 Day Volatility: 13.98%
50 Day Volatility: 22.09%
200 Day Volatility: 20.79%
Standard Deviation: 3.92%

DRGS - Technicals

DRGS Technicals

20 Day MA: $52.10
60 Day MA: $50.62
MACD 15 Period: 0.85
MACD 100 Period: 3.41
Williams % Range 10 Day: 1.00
Williams % Range 20 Day: 0.61
RSI 10 Day: 67
RSI 20 Day: 62
RSI 30 Day: 60
Ultimate Oscillator: 75

DRGS Bollinger Bands

Lower Bollinger (10 Day): $51.74
Upper Bollinger (10 Day): $53.94
Lower Bollinger (20 Day): $50.23
Upper Bollinger (20 Day): $53.96
Lower Bollinger (30 Day): $46.16
Upper Bollinger (30 Day): $55.39

DRGS Support & Resistance

Support Level 1: n/a
Support Level 2: $53.33
Resistance Level 1: n/a
Resistance Level 2: $53.33

DRGS Stochastic

Stochastic Oscillator %D (1 Day): 51.43
Stochastic Oscillator %D (5 Day): 93.57
Stochastic Oscillator %K (1 Day): 54.18
Stochastic Oscillator %K (5 Day): 86.96

DRGS Volatility

5 Day Volatility: 102.00%
20 Day Volatility: 13.98%
50 Day Volatility: 22.09%
200 Day Volatility: 20.79%
Standard Deviation: 3.92%

DRGS - ETFdb Realtime Rating & Analyst Report

DRGS is a passive ETN that seeks to replicate NYSE Arca Equal Weighted Pharmaceutical Total Return Index. The index is designed to track the performance of the equity securities of a cross-section of global companies involved in various phases of the development, production and marketing of pharmaceuticals.

ETFdb Category Expense Ratio Inception Date Issuer Structure YTD Return *
Health & Biotech Equities 0.6 2011-10-24 RBS ETN +25.04%

DRGS Realtime Rating: By Metric

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity C
Expenses C+
Performance ETFdb Pro Members Only
Volatility ETFdb Pro Members Only
Dividend ETFdb Pro Members Only
Concentration ETFdb Pro Members Only

The first adjacent table gives investors an individual Realtime Rating for DRGS on several different metrics, including liquidity, expenses, performance, volatility, dividend, and concentration of holdings. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities ETFdb Category with the highest Metric Realtime Rating for each individual field.

DRGS Realtime Rating: Overall

ETFdb Rating Type Overall Rating A+ Overall Rated ETF
Realtime Rating (Overall) ETFdb Pro Members Only ETFdb Pro Members Only

The second table shows the overall Realtime Rating for DRGS, as well as the A+ Overall Rated ETF in DRGS's Category. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

ETFdb Analyst Report for DRGS

This product offers exposure to a portfolio of global pharmaceutical companies, allowing investors to tap into a targeted corner of the health care sector that has the potential to deliver impressive returns in certain environments. Given the narrow focus, as well as the fact that the portfolio i...

Pro Membership Required to Continue Reading ETFdb Pro Members Only

To view the entire ETFdb Realtime Rating, you must be an ETFdb Pro member. To see all that is included in the ETFdb Realtime Rating, see the free previews of ten of the most popular ETFs: SPY, GLD, VWO, EFA, EEM, IVV, QQQ, TIP, VTI, LQD . Please login or begin your 14-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:

  • Register on ETFdb Get valuable insight from our analysts in the ETFdb Category reports, with in-depth breakdown every ETF niche, large or small.
  • Get portfolio guidance on nearly every possible investor scenario and include detailed information on risk profiles, asset correlation, portfolio management, and more.
  • Get access to our premium monthly newsletter ETF Edge.
  • Gain access to premium research reports covering popular sectors of the ETF industry.
  • Read in-depth monthly Q&A's with our Senior Analyst Michael Johnston.
  • Use the ETFdb Pro Screener to screen ETFs according to your own customized parameters, then download the results in Microsoft Excel format.
  • Get 100% access to the ETF Head-To-Head Comparison Tool, a resource that shows how more than 1,100 ETFs stack up against the competition in terms of performance, holdings, and technical strength.

Begin Your Free 14-Day Trial Now - or - Read more about ETFdb Pro

Latest DRGS News Stories

Search ETF Database

Enter a ticker symbol or keyword: